DNA Extraction Kits Market, By Product (Cell-free DNA, Genomic DNA, and Others), By Application (PCR, Sequencing, Cloning, and Others), By Sample Type (Blood, tissue & FFPE, Cells, and Others), By End User (Healthcare Facilities, Pharmaceutical and Biotechnology Company, Research Institutes, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Apr 2024

Code : CMI5230

Pages :165

Formats :

Excel and PDF

Industry : Biotechnology

Market Challenges – High Cost of DNA Extraction Kits

Technologically advanced DNA extraction kits are costlier than conventional methods. DNA extraction for a single sample or numerous samples of different sizes using different kits can be expensive. Furthermore, hazardous reagents used for more accurate and fast results can lead to impurities in results. DNA extraction is a basic process in molecular research studies and extracted DNA has many advanced downstream applications in the field of medicine. Extracted DNA is used in various applications such as Polymerase Chain Reaction (PCR), cloning, genome sequencing, and others. Using different DNA extraction kits for different applications makes the process expensive for end users in the market. The cost and time required for developing a single reagent for DNA extraction are high. Furthermore, DNA from various types of samples such as the human genome, plants, bacteria, forensic dried blood samples, etc., have distinct features and characteristics and need to be extracted or processed with the right DNA extraction methods. The cost of R&D increases, as key players are focused on developing next- generation, technologically advanced, high-yielding, and fast-processing DNA extraction kits. This, in turn, makes commercial DNA extraction kits expensive.

Market Opportunities – Availability of Next-generation DNA Extraction Kits

Increasing availability of next-generation DNA extraction kits by the key players in the market are expected to offer lucrative growth opportunities during the forecast period. DNA extraction is a common process in molecular biology laboratories. However, it is a tedious and time-consuming routine task. For instance, in May 2021, 30M Genomics, an India-based startup, developed a new technology called AmpReady, to extract DNA from biological samples without any equipment in five seconds. Moreover, in October 2020, Purigen Biosystems, Inc., a biotechnology company, announced the launch of Ionic Cells to Pure DNA Low Input Kit for researchers working with limited biological samples. The simplified and automated 60-minute workflow delivers high-quality DNA for rapid investigation of genetic abnormalities or examination of disease treatment effects.